Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Innocenti T, Hanžel J, Truyens M, Lukaš M, Gordon H, Cremer A, Molnár T, Julsgaard M, Onali S, Todeschini A, Nardone OM, Noor NM, Caprioli F, Scaldaferri F, Argyriou K, Savarino EV, Brinar M, Hedin CRH, Vela González M, Armuzzi A, Blesl A, Aratari A, Quadarella A, Parigi TL, Bertani L, Ferracane C, Uzzan M, Michalopoulos G, De Bernardi A, Katsanos K, Balestrieri P, Piñero G, Karmiris K, Casbas AG, Nikolic S, Felice C, Pugliese D, Pastras P, Mocci G, Pouillon L, Mantzaris GJ, Ramos L, Casanova MJ, Koutroubakis IE, García MJ, Lobaton T, Dragoni G, Study Group TJ.
Innocenti T, et al. Among authors: katsanos k.
J Crohns Colitis. 2026 Feb 5;20(2):jjaf188. doi: 10.1093/ecco-jcc/jjaf188.
J Crohns Colitis. 2026.
PMID: 41183095